JUAN JIMENEZ
Vehicle Board in Philadelphia, PA
License number
Pennsylvania MV102751L
Category
Vehicle Board
Type
Vehicle Salesperson
Address
Address
Philadelphia, PA 19133
Personal information
See more information about JUAN JIMENEZ at radaris.comName
Address
Phone
421 N 12Th St, Lebanon, PA 17046
424 E Allegheny Ave, Philadelphia, PA 19134
Professional information
See more information about JUAN JIMENEZ at trustoria.com
Project Director / Associate Producer At Idea Caption
Project Director / Associate Producer At Idea Caption
Position:
Project Director / Associate Producer at Idea Caption LLC, Associate Member / US Representation at BIODIVERSA COLOMBIA FOUNDATION
Location:
Greater Philadelphia Area
Industry:
Research
Work:
Idea Caption LLC
- Greater Philadelphia Area since Apr 2011
-
Project Director / Associate Producer
BIODIVERSA COLOMBIA FOUNDATION
- Colombia since Jan 2006
-
Associate Member / US Representation
ILTC/Programa Crianças Criativas (Creative Children Program)
- Brazil / USA Feb 2002 - Jun 2012
-
Interpreter and Translator / US Representation
Lingual Institute
- Greater Philadelphia Area Feb 2011 - May 2012
-
Portuguese Teacher / Portuguese Translator
TransPerfect Translations
- Greater Philadelphia Area Jun 2010 - May 2012
-
Interpreter (English/Spanish/Portuguese)
Global Arena
- Greater Philadelphia Area May 2009 - Oct 2011
-
Interpreter (English/Spanish/Portuguese)
Assurant Solutions
Jun 2007 - Apr 2010
-
Multilingual Claims Representative
Assurant Solutions
- 676 E Swedesford Road, Suite 300. Wayne, PA 19087 May 2009 - Jun 2009
-
Bilingual Trainer / Training Assistant
SurNeotropica Corporation
Feb 2005 - Apr 2007
-
Research and Project Director
Universidad Nacional de Colombia - Instituto de Ciencias Naturales
- University Main Campus, Bogota, Colombia Jan 2002 - Mar 2007
-
Arachnology Field and Lab Assistant
Education:
La Salle University 2010 - 2012
MA, Bilingual/Bicultural Studies Administrative Office of Pennsylvania Courts 2010 - 2010
Certification, Courts interpreter workshop Universidad Nacional de Colombia 1994 - 2004
Bachelor of Science, Biology INSTITUTO BUTANTAN 2003 - 2003
Internship, Natural History of Neotropical Tarantulas
MA, Bilingual/Bicultural Studies Administrative Office of Pennsylvania Courts 2010 - 2010
Certification, Courts interpreter workshop Universidad Nacional de Colombia 1994 - 2004
Bachelor of Science, Biology INSTITUTO BUTANTAN 2003 - 2003
Internship, Natural History of Neotropical Tarantulas
Skills:
Languages, Environmental Science, Translation, Life Sciences, Planning, Communication Strategies, Research, Spanish, Training & Development, Project Planning, Strategic Communications, Lifesciences, Employee Training, Data Analysis
Honor & Awards:
RESEARCH GRANTS: Sigma Xi, The Scientific Research Society - "2003 Grant-in-Aid of Research"
CONGRESSES & SCIENTIFIC MEETINGS
IV Meeting of South American Arachnologists. São Pedro, Brazil. 2003
Presentation: Taxonomy and geographical distribution of Theraphosidae tarantulas in Colombia.
Poster: Redescription of tarantula Hapalopus formosus. Rogerio Bertani, Juan Jacobo Jiménez.
II Colombian Congress of Zoology – Arachnology Symposium. Santa Marta, Colombia. 2006
Arachnology Symposium Coordinator.
Presentation: Tarantulas - Present status in Colombia.
Presentation: History of the research on the Order Araneae in Colombia.
Languages:
Spanish, Portuguese, English
Certifications:
Research Projects: development and management, IPÊ AMARELO
Courts interpreter workshop, Administrative Office of Pennsylvania Courts
Courts interpreter workshop, Administrative Office of Pennsylvania Courts
Vascular Stent Design
Vascular Stent Design
US Patent:
2011027, Nov 10, 2011
Filed:
Nov 25, 2008
Appl. No.:
12/744871
Inventors:
Peter F. Davies - Haverford PA, US
Juan M. Jimenez - Philadelphia PA, US
Juan M. Jimenez - Philadelphia PA, US
International Classification:
A61F 2/82
US Classification:
623 115, 623 142
Abstract:
This invention is directed to the design of radially expandable vascular stents to optimize hemodynamic flow characteristics that are favorable for the inhibition of stent-associated thrombosis, inflammation, and restenosis (neointimal formation) and that will reduce the risk of adverse events post-deployment.